ScoreWhy is Anthem Biosciences Ltd ?
1
Negative results in Dec 25
- PBT LESS OI(Q) At Rs 122.31 cr has Fallen at -24.2% (vs previous 4Q average)
- NET SALES(Q) At Rs 423.15 cr has Fallen at -18.3% (vs previous 4Q average)
- PAT(Q) At Rs 110.87 cr has Fallen at -14.1% (vs previous 4Q average)
2
With ROE of 17.7, it has a Very Expensive valuation with a 12.7 Price to Book Value
- Over the past year, while the stock has generated a return of 0.00%, its profits have risen by 35%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
No Data Found
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
29.80%
EBIT Growth (5y)
44.32%
EBIT to Interest (avg)
56.77
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.25
Sales to Capital Employed (avg)
0.62
Tax Ratio
28.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.96%
ROCE (avg)
32.59%
ROE (avg)
19.93%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
72
Industry P/E
31
Price to Book Value
12.71
EV to EBIT
57.77
EV to EBITDA
51.24
EV to Capital Employed
18.83
EV to Sales
19.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
32.59%
ROE (Latest)
17.74%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bollinger Bands
Mildly Bearish
KST
Dow Theory
No Trend
No Trend
OBV
Bearish
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-10What is not working for the Company
PBT LESS OI(Q)
At Rs 122.31 cr has Fallen at -24.2% (vs previous 4Q average
NET SALES(Q)
At Rs 423.15 cr has Fallen at -18.3% (vs previous 4Q average
PAT(Q)
At Rs 110.87 cr has Fallen at -14.1% (vs previous 4Q average
PBDIT(Q)
Lowest at Rs 157.19 cr.
Loading Valuation Snapshot...
Here's what is not working for Anthem Bioscienc
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 122.31 cr has Fallen at -24.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 161.44 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
At Rs 423.15 cr has Fallen at -18.3% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 517.81 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 110.87 cr has Fallen at -14.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 129.04 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Net Sales - Quarterly
Lowest at Rs 423.15 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 157.19 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 122.31 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
